Advances in Radiation Therapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer: From Technical Advances to Immunotherapy Integration
Naoya Murakami · 2026
Read Advances in Radiation Therapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer: From Technical Advances to Immunotherapy Integration by Naoya Murakami (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7129093688.txt.
Description
Naoya Murakami, a radiation oncologist at Juntendo University in Tokyo, wrote a 2026 review on treating lung cancer that is locally advanced and cannot be removed by surgery. This form of non-small cell lung cancer makes up a large share of cases and is hard to treat well.
Murakami traces three decades of change, from radiation alone to radiation combined with chemotherapy, and then to immune therapy or targeted drugs given afterward. A trial drug called durvalumab became standard care after combined treatment, and another drug helped patients whose tumors carry a specific gene change. He also warns that lung inflammation from radiation can be fatal, so dose limits and risk checks matter greatly.
Catalog record
| CREATOR | Naoya Murakami |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Juntendō Igaku/Juntendo igaku |